Vanda Pharmaceuticals Inc
vandapharma.comVanda Pharmaceuticals Inc (NASDAQ: VNDA) is a specialty pharmaceutical company that develops and commercializes drugs for central nervous system disorders and other conditions. Revenue comes primarily from product sales of its approved medicines, with royalties and licensing as secondary income streams. The 10-K filed February 12, 2026 (accession 000162828026007460) does not provide sufficient excerpted detail to specify segment revenue breakdowns, key competitors by name, geographic revenue mix, customer concentration figures, or founding and leadership history. Based solely on the available filing excerpts, further specifics on commercial products, market position, and capital structure cannot be confirmed. Any additional detail beyond what the excerpts support has been omitted per source-grounding requirements.
Products & Services
Not determinable from the provided filing excerpts.
Revenue Model
The available filing excerpts do not provide sufficient detail to describe the revenue model with specific figures or product-level breakdowns.
Customers & Markets
Not determinable from the provided filing excerpts.
Geographic Exposure
Not determinable from the provided filing excerpts.
Financial Snapshot
Loading...
